Wilms tumor
ICD-10 C64.1 · ICD-11 2C90.Y&XH5QN3

Treatment of Wilms Tumor in Children with Metastatic Bilateral Renal Tumors (Favorable Histology)

Children presenting with metastatic bilateral favorable-histology Wilms tumor represent a distinct clinical scenario. Bilateral involvement and metastatic extent require a carefully coordinated approach that prioritizes both tumor control and preservation of renal function.

Clinical Scenario

This protocol applies to children with metastatic bilateral renal tumors (favorable histology Wilms tumor), with or without a predisposing condition. The bilateral nature of the disease is a defining factor that shapes both the systemic and surgical strategy.

Treatment Goals

The primary objectives are complete tumor response and achieving resectability of bilateral tumors, assessed at a defined interval following the initiation of systemic therapy. Nephron-sparing surgery — preserving as much renal function as possible — is a central surgical goal.

Approach (Partial Overview)

The recommended approach begins with neoadjuvant combination chemotherapy using the VAD regimen, delivered before any surgical intervention. Tumor response is formally reassessed at six weeks to determine whether and when nephron-sparing surgery can proceed.

Full regimen details, complete dosing, surgical timing criteria, and the step-by-step decision algorithm are available in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.6004/jnccn.2021.0037

View source ↗